Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 12:10:363.
doi: 10.3389/fneur.2019.00363. eCollection 2019.

Autonomic Dysfunction in α-Synucleinopathies

Affiliations
Review

Autonomic Dysfunction in α-Synucleinopathies

José Javier Mendoza-Velásquez et al. Front Neurol. .

Abstract

The α-synucleinopathies are a group of neurodegenerative diseases characterized by abnormal accumulation of insoluble α-synuclein in neurons and glial cells, comprising Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although varying in prevalence, symptom patterns, and severity among disorders, all α-synucleinopathies have in common autonomic nervous system dysfunctions, which reduce quality of life. Frequent symptoms among α-synucleinopathies include constipation, urinary and sexual dysfunction, and cardiovascular autonomic symptoms such as orthostatic hypotension, supine hypertension, and reduced heart rate variability. Symptoms due to autonomic dysfunction can appear before motor symptom onset, particularly in MSA and PD, hence, detection and quantitative analysis of these symptoms can enable early diagnosis and initiation of treatment, as well as identification of at-risk populations. While patients with PD, DLB, and MSA show both central and peripheral nervous system involvement of α-synuclein pathology, pure autonomic failure (PAF) is a condition characterized by generalized dysregulation of the autonomic nervous system with neuronal cytoplasmic α-synuclein inclusions in the peripheral autonomic small nerve fibers. Patients with PAF often present with orthostatic hypotension, reduced heart rate variability, anhydrosis, erectile dysfunction, and constipation, without motor or cognitive impairment. These patients also have an increased risk of developing an α-synucleinopathy with central involvement, such as PD, DLB, or MSA in later life, possibly indicating a pathophysiological disease continuum. Pathophysiological aspects, as well as developments in diagnosing and treating dysautonomic symptoms in patients with α-synucleinopathies are discussed in this review.

Keywords: Parkinson disease; autonomic dysfunction; dementia with Lewy bodies; dysautonomia; multiple system atrophy; pure autonomic failure; α-synucleinopathies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. McCann H, Stevens CH, Cartwright H, Halliday GM. α-Synucleinopathy phenotypes. Park Relat Disord. (2014) 20(Suppl.1):S62–7. 10.1016/S1353-8020(13)70017-8 - DOI - PubMed
    1. Coon EA, Low PA. Pure autonomic failure without alpha-synuclein pathology: an evolving understanding of a heterogeneous disease. Clin Auton Res. (2017) 27:67–8. 10.1007/s10286-017-0410-1 - DOI - PMC - PubMed
    1. Kaufmann H, Goldstein DS. Editorial: pure autonomic failure: a restricted lewy body synucleinopathy or early parkinson disease? Neurology. (2010) 74:536–7. 10.1212/WNL.0b013e3181d26982 - DOI - PubMed
    1. Palma J-A. Autonomic dysfunction in Parkinson's disease and other synucleinopathies: introduction to the series. Mov Disord. (2018) 33:347–8. 10.1002/mds.27347 - DOI - PMC - PubMed
    1. Leclair-Visonneau L, Magy L, Volteau C, Clairembault T, Le Dily S, Préterre C, et al. . Heterogeneous pattern of autonomic dysfunction in Parkinson's disease. J Neurol. (2018) 265:933–41. 10.1007/s00415-018-8789-8 - DOI - PubMed

LinkOut - more resources